The global dental imaging market was US$ 3.12 billion in 2024, is forecast at US$ 3.35 billion in 2025, and is expected to reach US$ 6.42 billion by 2034 (CAGR 7.46% from 2025–2034), driven by digital imaging (CMOS/PSP), CBCT adoption, AI/software uptake and expanding use in implantology and orthodontics.
Download the free sample and get the complete insights and forecasts report on this market @ https://www.towardshealthcare.com/download-sample/6039
Baseline (2024): Market value stood at US$ 3.12 billion (reported 2024 actual).
Near term (2025): Projected to reach US$ 3.35 billion in 2025 — an increase of US$ 0.23 billion (+7.37% vs 2024).
Long-term (2034): Projected at US$ 6.42 billion by 2034 under the supplied forecast.
CAGR (2025→2034): 7.46% annual growth rate is the basis for the 2034 projection.
Absolute growth (2025→2034): US$ 3.07 billion growth in total nominal value (from 3.35 → 6.42), a ~91.64% cumulative increase over those nine years.
Absolute growth (2024→2034): US$ 3.30 billion increase (3.12 → 6.42), a ~105.77% cumulative increase across the 10-year window.
Average nominal annual increase (2025→2034): about US$ 0.341 billion per year (3.07 / 9 years) in nominal dollars.
CAGR consistency check: applying 7.46% annually to US$3.35 across nine years yields approximately US$ 6.40–6.42 billion (rounding differences explain the tiny gap), confirming consistency between the CAGR and the stated 2034 projection.
Market scale context: the market roughly doubles (≈+100%) from 2024 to 2034; this implies persistent investment in imaging hardware, software and related services.
Implication for stakeholders: steady, mid-single-digit to low-double-digit returns over the decade — attractive for device makers, software/AI vendors and DSOs investing in standardized imaging workflows.
Digital imaging supremacy (technology shift):
The digital (CMOS/PSP) segment accounted for ~88% of market revenue in 2024, showing near-ubiquitous migration from film/analog to digital sensors and plates.
Impact: faster captures, instant image transfer to software, simplified EHR integration and reduced running costs for clinics.
Intraoral imaging dominance (modality):
Intraoral imaging led with 34% revenue share in 2024 — it’s the everyday diagnostic backbone (bitewings, periapicals, sensors).
Impact: broad footprint across independent clinics and routine dentistry.
Rapid CBCT adoption (modalities shifting toward 3D):
CBCT is the fastest-growing modality, driven by implantology, surgery and orthodontics where 3D data materially improves planning and outcomes.
Software becoming revenue center (imaging acquisition & 3D planning):
Imaging acquisition & 3D planning software accounted for ~58% market share in 2024 — software is now as strategic as hardware.
Impact: recurring revenue models through licenses, cloud services, and integration fees.
AI/Automation accelerating (emerging but fastest CAGR among software):
AI/automation is expected to grow at the fastest CAGR among software segments — automating detection (caries, pathology), supporting treatment planning, and reducing clinician time per case.
Clinical application concentration in implantology & oral surgery:
Implantology & oral surgery were the largest single clinical application (~32% share) in 2024 — driving demand for CBCT and advanced planning software.
Orthodontics — fastest application growth:
Orthodontics (aligner planning, 3D dental arch analysis) is expected to post the fastest CAGR, benefiting from intraoral scanners and CBCT integration with aligner workflows.
End-user split — independent clinics dominate but DSOs grow fastest:
Independent dental clinics held ~54% share in 2024, reflecting the sector’s fragmented provider base — but DSOs/group practices are the fastest growing end-user segment (scale investments, centralized imaging strategies).
Geography: North America leader, APAC fastest growth:
North America led with ~39% revenue share in 2024. Asia-Pacific expected to register the fastest CAGR driven by infrastructure investments and rising cosmetic dentistry demand.
Product and detection tech cycles:
Frequent product launches (new scanners, detectors, lower-dose hardware) and detector portfolio updates (e.g., flat panels with better dynamic range) are shortening replacement cycles for clinics aiming to stay competitive.
Regulatory & radiation safety concerns persist:
Even as dose-reduction tech improves, radiation safety concerns are a restraining factor affecting frequency of scans (especially in pediatric and sensitive populations).
Integration & chairside workflows matter:
Buyers increasingly value systems that integrate imaging, 3D planning and practice management — the “one-stop” digital workflow can be a decisive purchasing factor.
Automated pathology detection (caries, lesions, bone loss)
Role: AI models flag probable caries, periapical lesions, bone loss and other pathologies on 2D/3D images.
Impact: reduces missed findings, speeds triage, and supports second-opinion workflows.
Example link to supplied content: firms like Pearl AI, Overjet, and VideaHealth are named as market players specializing in AI detection.
3D treatment planning & implant placement assistance
Role: AI automates segmentation of bone and vital structures, suggests optimal implant positions and simulates outcomes.
Impact: reduces planning time for implantology & oral surgery (the leading application at ~32% share), improves surgical accuracy, and lowers complication risk.
Real-world tie: imaging acquisition & 3D planning software dominance (58% share) creates a natural platform for embedded AI tools.
Image quality enhancement & dose optimization
Role: AI denoising and reconstruction techniques enable clinically usable images at lower radiation doses.
Impact: addresses radiation safety concerns and increases clinician confidence to use 3D imaging when appropriate.
Automated measurement, landmarking and cephalometric analysis
Role: AI places cephalometric landmarks, measures angles/linear distances, and generates orthodontic reports.
Impact: speeds orthodontic workflows and supports the fast-growing aligner and orthodontics segment.
Workflow automation & case prioritization
Role: AI triages images arriving at a cloud/PACS server, prioritizes urgent cases and routes them to specialists.
Impact: improves throughput in DSOs and hospitals, reduces turnaround time for urgent findings.
Clinical decision support / predictive analytics
Role: AI aggregates image findings with patient records to predict treatment outcomes, risk of implant failure or progression of disease.
Impact: enables personalized treatment planning and better patient counseling (higher acceptance rates).
Quality assurance, compliance & audit trails
Role: AI flags inconsistent imaging protocols, incomplete captures or suboptimal exposures for operator feedback.
Impact: raises diagnostic quality and provides documentation for regulatory and reimbursement audits.
Augmented reality / visualization support for chairside communication
Role: AI converts image/3D planning data into patient-facing visualizations, overlays and treatment simulations.
Impact: improves patient understanding and consent, supporting case acceptance for cosmetic & implant procedures.
Scalability for DSOs & cloud platforms
Role: AI deployed in cloud/PACS environments scales analyses across networks of clinics.
Impact: DSOs can standardize diagnostics across multiple sites, improving quality control and enabling centralized review.
Commercial models & monetization (SaaS/AI licensing)
Role: AI creates recurring revenue streams (per-scan or subscription) layered on hardware sales.
Impact: shifts vendor economics from single-unit hardware sales to software/AI subscription, increasing customer lifetime value; aligns with the dominance of imaging acquisition & 3D planning software (58% share).
Drivers: mature dental care market, high per-capita dental spending, strong private sector reimbursement in many cases, high adoption of cosmetic dentistry and implants.
Technology preferences: rapid adoption of CBCT, advanced digital sensors, and integrated chairside scanners — vendors focus on workflow integration and service contracts.
Buyer behavior: preference for complete solutions (hardware + software + service) and strong demand from DSOs for standardized imaging across networks.
Barriers: cost sensitivity in smaller practices remains; radiation safety awareness encourages dose optimization.
Growth factors: large DSO presence, favorable reimbursement for diagnostic imaging in some contexts, high patient willingness to pay for cosmetic/implant treatments.
Innovation hub: many product launches and partnerships (examples given in content: Planmeca–Benevis, DEXIS new solutions, Align iTero launch).
Drivers: government-backed healthcare system for general medicine (but dentistry largely private/insured), increasing preventive/cosmetic dental attention, adoption of digital radiography and CBCT in urban centers.
Challenges: smaller market scale vs US, geographic dispersion increases installation/maintenance logistics costs.
Drivers: rising middle-class disposable income, expanding dental infrastructure, increased awareness of oral health and cosmetic dentistry, and government investments in healthcare infrastructure.
Country highlights: China, Japan, India, South Korea and Thailand cited as key markets — each with different adoption curves (Japan/ROK: faster adoption and high-end tech; China/India: rapid volume growth and increasing mid-tier device adoption).
Opportunities: lower per-unit market penetration vs North America suggests long runway for device and software sales; local partnerships and price-sensitive product lines will be key.
Drivers: strong clinical standards, early adoption of digital dental tech in Western Europe, steady investment in CBCT for specialized centers.
Regulatory environment: EU medical device regulations and country-level reimbursement/regulatory idiosyncrasies guide adoption pace.
Drivers: growing awareness and demand for cosmetic dentistry, urban clinics investing in digital workflows.
Barriers: price sensitivity and fragmented provider base; selective adoption of higher-end CBCT systems more likely in private specialist centers.
Drivers: pockets of high investment (e.g., UAE, Saudi Arabia) and growing private healthcare clusters.
Barriers: overall market smaller, heterogeneous regulations and variable access to financing for equipment.
Rising prevalence of dental disorders & aging populations → higher diagnostic demand.
Digital transformation of dentistry → conversion to CMOS/PSP sensors, intraoral scanners and CBCT. (Digital = 88% share.)
Growth in implantology & cosmetic dentistry → drives CBCT and 3D planning software (implantology & oral surgery = 32% share).
DSO expansion and standardization → larger centralized purchases and software platform adoption.
AI & cloud software proliferation → software revenue growth and recurring license models (imaging acquisition & 3D planning software = 58% share).
Radiation safety concerns → cautious use of repeated scans, especially in pediatric/young adult cohorts.
Capital cost & ROI concerns for high-end CBCT → slows adoption in small clinics despite clinical benefits.
Fragmented provider market → slows standardized procurement and complicates after-sales service networks.
Regulatory constraints → device approvals and data privacy rules can delay product launches in specific regions.
3D and CBCT market expansion → high-value devices with software add-ons; cross-sell opportunities.
AI integration for diagnostics & workflow → high CAGR for AI/automation software.
Subscription & cloud models → recurring revenue from imaging software, AI reads, and cloud PACS.
Emerging markets (APAC) → fastest growth potential with increasing private dental spend.
Detector & low-dose innovations → new hardware offerings that reduce radiation concerns.
R&D & product development — device sensors (CMOS, photon-counting), CBCT hardware, reconstruction algorithms, AI model training. (Key: Dentsply Sirona, Planmeca, detection tech examples.)
Manufacturing & component sourcing — detectors, X-ray tubes, mechanical assemblies; supply chain critical for uptime.
Packaging, sterilization & logistics — traceability for sensors/consumables and safe delivery to clinics.
Distribution & sales — direct sales to DSOs/large clinic chains and indirect to independent clinics via dealers.
Installation & training — clinical onboarding for CBCT and 3D planning systems.
Software licensing & cloud services — imaging acquisition, 3D planning, AI reads, PACS.
Patient support & services — maintenance contracts, remote diagnostics, upgrades. (Key players: Sirona, Carestream, Vatech cited.)
Dentsply Sirona
Products: comprehensive dental equipment portfolio including imaging hardware and software platforms.
Overview: one of the largest integrated dental manufacturers with solutions spanning imaging, restorative and CAD/CAM workflows.
Strengths: broad distribution network, integrated hardware+software ecosystem, large installed base enabling upsell of software and services.
Envista Holdings (DEXIS / KaVo Imaging / i-CAT)
Products: intraoral sensors/solutions (DEXIS), imaging systems (KaVo) and CBCT (i-CAT).
Overview: multi-brand strategy covering sensor to CBCT segments.
Strengths: brand portfolio that addresses both entry/intermediate and high-end markets; cross-brand channel coverage.
Planmeca
Products: CBCT units, 2D/3D imaging devices, and integrated software solutions.
Overview: established supplier of integrated imaging+planning systems.
Strengths: strong software integration, focus on R&D and practice workflow optimization (e.g., partnerships with US networks such as Benevis noted in supplied content).
Carestream Dental
Products: digital radiography, CBCT, 3D imaging and image management software.
Overview: long-standing imaging specialist serving clinics and hospitals.
Strengths: imaging-first reputation, service and maintenance footprint, and imaging workflow expertise.
Vatech
Products: CBCT, intraoral sensors and imaging software.
Overview: hardware and software vendor with growing AI partnerships.
Strengths: recent partnership with Pearl (March 2025) to integrate AI pathology detection, signaling strength in strategic collaborations and software enhancement.
ACTEON Group
Products: imaging equipment (panoramic, intraoral), surgical/implant devices.
Overview: specialist dental imaging and equipment supplier.
Strengths: product specialization and clinical focus that supports imaging use across multiple dental disciplines.
Align Technology
Products: intraoral scanners (iTero family), digital orthodontic/aligner workflow solutions.
Overview: known for strong position in orthodontic imaging and digital impression ecosystems.
Strengths: deep integration with aligner workflows, product innovation (e.g., iTero Lumina launch Jan 2024), and a captive downstream market (aligner users).
Medit
Products: intraoral scanners and associated software ecosystem.
Overview: scanner-centric vendor offering open workflow integrations.
Strengths: focus on scanner accuracy, developer-friendly ecosystem and competitive price/performance in intraoral scanning.
NewTom (Cefla Group)
Products: CBCT and advanced 3D imaging equipment.
Overview: CBCT specialist under a larger industrial group.
Strengths: niche CBCT expertise, targeted product lines for surgical/implant planning.
Pearl AI (representative AI vendor)
Products: AI pathology detection and diagnostic assistance tools for dental images.
Overview: AI software house focused on automating pathology detection and streamlining radiology reads in dentistry.
Strengths: algorithmic focus, partnerships with hardware vendors (e.g., VATECH partnership March 2025) and ability to integrate into imaging software/PACS.
VATECH + Pearl partnership — March 2025
What happened: VATECH partnered with Pearl to integrate Pearl’s AI-driven pathology detection into VATECH’s imaging software.
Why it matters: Embeds AI into the device vendor’s workflow, improving diagnostic precision and streamlining reads; creates a packaged hardware+AI offering for clinics and DSOs, accelerating AI adoption.
Detection Technology — upgraded flat panel X-ray detector portfolio — Nov 2024 (RSNA)
What happened: Launched a portfolio of 20 flat panel detectors boasting high frame rates, improved image quality at low doses and a wide dynamic range.
Why it matters: Detector innovation drives image quality improvements and supports low-dose capabilities — essential for both medical and dental imaging expansion into hybrid and surgical applications.
DEXIS (Envista) — three new solutions — Sept 2024
What happened: DEXIS rolled out three new solutions to strengthen its digital ecosystem, emphasizing connectivity and simplified workflows.
Why it matters: Demonstrates vendor focus on practice efficiency and interoperability — features buyers increasingly demand.
Align Technology — iTero Lumina launch — Jan 2024
What happened: iTero Lumina launched with a 45% smaller and 50% lighter design and a three-times wider capture field.
Why it matters: Improved ergonomics and capture area accelerate intraoral scanning efficiency — helps orthodontic and restorative workflows.
XpectVision — edge photon-counting intraoral sensor — July 2024
What happened: Introduced an intraoral sensor using photon-counting technology to reduce light scattering and improve direct dental imaging quality.
Why it matters: Photon-counting tech is promising for higher image fidelity and dose efficiency — potential paradigm shift for sensors.
Dental Imaging Technologies — ORTHOPANTOMOGRAPH OP 3D LX — July 2024
What happened: Launched an OP 3D LX unit with flexible FOV options (5×5 cm to 15×20 cm).
Why it matters: Flexibility in FOV makes the system applicable across multiple specialties — from endodontics to complex surgery.
Planmeca — strategic partnership with Benevis — Feb 2024
What happened: Planmeca partnered with Benevis (120 dental offices) to broaden access and collaboration.
Why it matters: Vendor–provider partnerships accelerate equipment deployment and long-term service relationships.
Hardware + AI bundling trend (VATECH + Pearl):
Implication: Device vendors are moving beyond hardware sales to integrated AI-enabled offerings; clinics benefit from out-of-the-box AI reads; software monetization grows.
Detector & sensor innovations (Detection Technology, XpectVision):
Implication: Improvements in panels and photon-counting sensors improve image quality while enabling lower doses — may ease radiation safety concerns and expand CBCT use in marginal cases.
Scanner ergonomics & workflow improvement (iTero Lumina):
Implication: Smaller, lighter intraoral scanners reduce operator fatigue and increase throughput — this supports faster chairside workflows and higher patient throughput.
Flexible FOV CBCTs (ORTHOPANTOMOGRAPH OP 3D LX):
Implication: Multi-FOV systems allow clinics to invest in a single device for broader case coverage — better ROI and cross-specialty utilization.
Vendor–DSO partnerships (Planmeca–Benevis):
Implication: Direct partnerships with clinic chains accelerate deployments, create long-term service agreements and standardize imaging practices across networks.
Software share growth (58% for imaging acquisition & 3D planning):
Implication: Software will increasingly be the value driver: licensing, upgrades and cloud services become central to vendor strategies.
Regulatory & safety conversation intensifies:
Implication: Vendors that can demonstrate dose optimization and validated AI accuracy will have competitive advantage.
Fragmentation to consolidation among providers:
Implication: As DSOs grow, they create larger, repeatable procurement opportunities — attractive for vendors who can supply multi-site solutions and central PACS/AI.
Intraoral Imaging (sensors, PSP scanners, intraoral X-ray units)
Role: Primary diagnostic tool for routine dentistry — caries detection, periapicals.
Commercial: High unit volumes, widely installed, major recurring sensor/maintenance revenue.
Panoramic / Pan-Ceph 2D
Role: Broad dental overview imaging for orthodontics and general diagnosis.
Commercial: Staple device across general practices; replacement cycle longer than intraoral sensors.
Cone-Beam CT (CBCT)
Role: 3D imaging for implant planning, surgery, endodontics and orthodontics.
Commercial: Higher unit price, longer sales cycle, but higher ASP and software add-on monetization.
Intraoral Scanners (IOS)
Role: Digital impressions for prosthodontics and orthodontics (aligner planning).
Commercial: Vendor competition on accuracy, ease of use and ecosystem integrations.
Other (fluorescence, near-infrared caries detection, cameras)
Role: Adjunctive diagnostics; early caries detection and soft tissue imaging.
Commercial: Niche but growing; supports preventive dentistry initiatives.
Digital (CMOS/PSP) — dominant (≈88% revenue).
Benefits: Instant imaging, digital storage, workflow integration, and lower per-scan marginal costs.
Analog / Film — legacy.
Declining use, mostly sidelined in modern practices except niche/low-resource settings.
Imaging Acquisition & 3D Planning — dominated the market (~58%).
Function: Capture, reconstruct, plan implants/surgeries and deliver surgical guides.
AI / Automation
Function: Automated detection, segmentation, predictive analytics — fastest CAGR among software.
Visualization / Communication & Cloud PACS
Function: Cloud storage, patient communication, remote consults and multi-site sharing.
Implantology & Oral Surgery — largest application (~32%).
Needs: CBCT, surgical planning, guided surgery integration.
Orthodontics — fastest growing application.
Needs: Intraoral scanners, cephalometric analysis and aligner planning integration.
Endodontics, Periodontics, General Dentistry, TMJ & Airway
Each has specific imaging FOV and resolution needs (e.g., high-res for endodontic canals).
Independent Dental Clinics — largest share (~54%).
Characteristics: Fragmented, wide diversity in buying power.
DSOs / Group Practices — fastest growth.
Characteristics: Centralized purchasing, standardized imaging networks and preference for cloud/PACS.
Hospitals / Academic Institutions — use high-end CBCT and cross-department capabilities.
Dental Labs & Imaging Centers — provide outsourced imaging and 3D model generation for clinics.
North America, Asia-Pacific (fastest growth), Europe, Latin America, MEA with their respective drivers and constraints.
Q: What is the current size and near-term growth of the dental imaging market?
A: The market was US$ 3.12 billion in 2024, projected at US$ 3.35 billion in 2025, and expected to reach US$ 6.42 billion by 2034, growing at a 7.46% CAGR between 2025 and 2034.
Q: Which region leads the dental imaging market and which is growing fastest?
A: North America led with roughly 39% share in 2024; Asia-Pacific is forecast to register the fastest CAGR during the projection period.
Q: Which technologies and modalities dominate the market today?
A: Digital (CMOS/PSP) technology dominated (~88% of revenue in 2024). Intraoral imaging was the largest modality (~34% share), while CBCT is the fastest-growing modality.
Q: How is AI affecting dental imaging?
A: AI is accelerating diagnostics (automated pathology detection), enhancing 3D planning, improving image quality/dose reduction, automating workflows and creating recurring software revenue. AI/automation is expected to post the fastest CAGR among software segments.
Q: Who are the main players in the market and what are the major recent strategic moves?
A: Top players include Dentsply Sirona, Envista (DEXIS/KaVo/i-CAT), Planmeca, Carestream, Vatech, ACTEON, Align, Medit, NewTom (Cefla), Pearl AI and others. Notable recent moves: VATECH–Pearl partnership (Mar 2025) for AI integration; Detection Technology’s flat panel portfolio (Nov 2024); DEXIS new digital solutions (Sept 2024); Align’s iTero Lumina launch (Jan 2024).
Access our exclusive, data-rich dashboard dedicated to the dental sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/6039
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Powering Healthcare Leaders with Real-Time Insights: https://www.towardshealthcare.com/healthcare-intelligence-platform
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
AI in Healthcare Market is projected to grow from USD 37.98 billion in 2025 to USD 674.19 billion by 2034… Read More
The global digital health market was USD 335.51 billion in 2024 and — depending on the projection in your text… Read More
The global cell therapy market estimated at USD 5.88 billion in 2024 (reported) and USD 7.21 billion in 2025 —… Read More
The global biotechnology market is projected to grow from USD 1,744.83 billion in 2025 to USD 5,036.46 billion by 2034 … Read More
The global digital health and wellness market is projected to expand from US$ 498.99 billion in 2024 to US$ 3,568.11… Read More
The global radiopharmaceutical market is projected to grow from USD 6.8 billion in 2024 to USD 14.11 billion by 2034,… Read More